Breathe Well Live Well
 Economic Times |
India revokes patent for Merck asthma drug
Economic Times NEW DELHI: India has revoked a patent for an asthma drug held by US-based Merck following a challenge from local pharmaceutical giant Cipla, marking a new blow to global drug firms in the Indian market. The development is the latest in a string of … India revokes patent on Merck asthma drug Merck loses patent for asthma drug India Revokes Patent on Merck Asthma Drug -Reuters |
View full post on asthma – Google News
|
India revokes patent on Merck & Co asthma drug
Yahoo! News (blog) MUMBAI (Reuters) – India has revoked a patent granted to an asthma drug made by Schering Corp, later bought by U.S.-based Merck & Co, citing lack of invention, after Indian drugmaker Cipla Ltd challenged an earlier decision. The move is the latest in a … |
View full post on asthma – Google News
|
India revokes patent on Merck & Co asthma drug
Reuters MUMBAI (Reuters) – India has revoked a patent granted to an asthma drug made by Schering Corp, later bought by U.S.-based Merck & Co, citing lack of invention, after Indian drugmaker Cipla Ltd challenged an earlier decision. The move is the latest in a … |
View full post on asthma – Google News